Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313592) titled 'Whole Genome Sequencing (ChromoSeq(R)) for Acute Lymphoblastic Leukemia (ALL) Patients' on Dec. 17, 2025.

Study Type: Observational

Primary Sponsor: Washington University School of Medicine

Condition: Acute Lymphoblastic Leukemia

Intervention: Device: ChromoSeq(R) assay testing

Recruitment Status: Not recruiting

Date of First Enrollment: January 31, 2026

Target Sample Size: 60

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07313592

Published by HT Digital Content Services with permission from Health Daily Digest....